Leveque N, Brouchet L, Lepage B, Hermant C, Bigay-Game L, Plat G, Dahan M, Riviere D, Didier A, Mazieres J
Unité d'oncologie cervico-thoracique-clinique des voies, service de pneumologie, université Paul-Sabatier, hôpital Larrey, CHU de Toulouse, chemin de Pouvourville, 31059 Toulouse cedex, France.
Service de chirurgie thoracique, université Paul-Sabatier, hôpital Larrey, CHU de Toulouse, 31059 Toulouse, France.
Rev Mal Respir. 2014 Mar;31(3):208-13. doi: 10.1016/j.rmr.2013.10.001. Epub 2013 Oct 28.
Lung cancer is the main cause of cancer death in France. The diagnosis is often late and the delay between the onset of symptoms and management is considered an aggravating factor.
Our prospective study collected the dates of the start of management of 139 consecutive patients receiving first line treatment for thoracic cancer in our hospital between November 2008 and May 2009. The aim of this study was to evaluate the delays in medical or surgical treatments in patients with thoracic cancer and to determine the cause of these delays.
The median delay between the first abnormal chest X-ray and treatment was 9.6 weeks. The delays were significantly shorter in the late stages and in small cell cancer (P=0.001). There was a tendency for shorter delays in women and for longer delays in older patients.
Evaluation of the delays in treatment, particularly in the early stages, is part of the quality control of management of these diseases.
肺癌是法国癌症死亡的主要原因。诊断往往较晚，症状出现与治疗之间的延迟被认为是一个加重因素。
我们的前瞻性研究收集了2008年11月至2009年5月期间在我院连续接受一线治疗的139例胸段癌患者的治疗开始日期。本研究的目的是评估胸段癌患者的药物或手术治疗延迟情况，并确定这些延迟的原因。
首次胸部X线异常与治疗之间的中位延迟为9.6周。晚期和小细胞癌的延迟明显较短（P=0.001）。女性延迟倾向于较短，老年患者延迟倾向于较长。
评估治疗延迟，特别是早期的延迟，是这些疾病管理质量控制的一部分。
Zotero 插件